Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Wataru Hirose, Kenichiro Nishikawa, Masuko Hirose, Toshihiro Nanki & Hideharu Sugimoto. (2009) Response of early active rheumatoid arthritis to tumor necrosis factor inhibitors: evaluation by magnetic resonance imaging. Modern Rheumatology 19:1, pages 20-26.
Read now
Read now
Tove Riise, Bjarne Koster Jacobsen, Jan Tore Gran. (2001) Changes in therapy of rheumatoid arthritis during the period 1979 to 1996. Scandinavian Journal of Rheumatology 30:4, pages 199-202.
Read now
Read now
Ritva Peltomaa, Leena Paimela, Tapani Helve, Marjatta Leirisalo-Repo. (2001) Effect of treatment on the outcome of very early rheumatoid arthritis. Scandinavian Journal of Rheumatology 30:3, pages 143-148.
Read now
Read now
Tadamasa Hanyu, Katsumitsu Arai & Hajime Ishikawa. (1999) Long-term methotrexate (MTX) combination therapy versus MTX alone for active rheumatoid arthritis. Japanese Journal of Rheumatology 9:1, pages 31-44.
Read now
Read now
Articles from other publishers (15)
Mikiko SHIMIZU, Eisuke MIZUTANI, Tsuyoshi SHIGA & Masayuki HASHIGUCHI. (2022) Comparison of Clinical Equivalence of Infliximab and its Biosimilar Combinations with Methotrexate in the Treatment of Rheumatoid Arthritis. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 53:2, pages 15-24.
Crossref
Crossref
Ryosuke Yukiya, Takashi Kajita, Yoshiko Okuda, Norifumi Ebisuura, Makoto Kuromatsu, Mai Taruno, Arisa Okawara, Hiroyasu Ishimaru, Kazuhiro Hatta, Tomoyuki Okuno & Mutsuaki Ueda. (2020) An educational approach by a pharmacy department to patients with rheumatoid arthritis aiming at improvement of medication adherence to methotrexate therapy関節リウマチ患者のメトトレキサート服薬アドヒアランスの向上を目指した薬剤部の取り組み. Tenri Medical Bulletin 23:2, pages 104-112.
Crossref
Crossref
Harvinder S. Luthra. 2018. Morrey's the Elbow and its Disorders. Morrey's the Elbow and its Disorders
731
741
.
Kentaro Inui & Tatsuya Koike. (2016) Combination therapy with biologic agents in rheumatic diseases: current and future prospects. Therapeutic Advances in Musculoskeletal Disease 8:5, pages 192-202.
Crossref
Crossref
Harvinder S. Luthra. 2009. Morrey's The Elbow and Its Disorders. Morrey's The Elbow and Its Disorders
1025
1038
.
Tsuneyo Mimori. (2008) 3. Anti-inflammatory Agents and Corticosteroids for Treatment of Rheumatoid Arthritis. Nihon Naika Gakkai Zasshi 97:10, pages 2393-2398.
Crossref
Crossref
Daniel Clemente, César Hernández-García, Lydia Abásolo, Virginia Villaverde, Cristina Lajas, Estíbaliz Loza, Ruth López-González, Cristina Vadillo, Benjamín Fernández-Gutiérrez, Inmaculada Morado & Juan Ángel Jover. (2007) Disminución del tiempo hasta el primer tratamiento con fármacos modificadores de la enfermedad en pacientes con artritis reumatoide. Reumatología Clínica 3:6, pages 245-250.
Crossref
Crossref
Daniel Clemente, César Hernández-García, Lydia Abásolo, Virginia Villaverde, Cristina Lajas, Estíbaliz Loza, Ruth López-González, Cristina Vadillo, Benjamín Fernández-Gutiérrez, Inmaculada Morado & Juan Ángel Jover. (2007) Reduction in Time Until First Treatment With Disease Modifying Treatment in Patients With Rheumatoid Arthritis. Reumatología Clínica (English Edition) 3:6, pages 245-250.
Crossref
Crossref
Peter K. Schädlich, Henning Zeidler, Angela Zink, Erika Gromnica-Ihle, Matthias Schneider, Christoph Straub, Josef G. Brecht & Eduard Huppertz. (2012) Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany. PharmacoEconomics 23:4, pages 377-393.
Crossref
Crossref
Mansho Itokazu, Matsunaga Takanobu & Yoshifumi Oshita. (1995) Efficacy and safety of auranofin in patients with active early rheumatoid arthritis. Clinical Therapeutics 17:1, pages 60-73.
Crossref
Crossref
Daniel J. McCarty. (1993) Personal experience in the treatment of seropositive rheumatoid arthritis with drugs used in combination. Seminars in Arthritis and Rheumatism 23:2, pages 42-49.
Crossref
Crossref
Peter T. Dawes & Deborah P.M. Symmons. (1992) Short-term effects of antirheumatic drugs. Baillière's Clinical Rheumatology 6:1, pages 117-140.
Crossref
Crossref
Herbert Kaplan. (1983) Auranofin: Bane or bonanza for the nonrheumatologist. The American Journal of Medicine 75:6, pages 145-151.
Crossref
Crossref
Donald C. Ferlic, Charley J. Smyth & Mack L. Clayton. (1983) Medical considerations and management of rheumatoid arthritis. The Journal of Hand Surgery 8:5, pages 662-666.
Crossref
Crossref
. (2005) Supplement: 21st rheumatism review. Arthritis & Rheumatism 17:5, pages 651-910.
Crossref
Crossref